Metoclopramide hydrochloride hydrate Size:Contact [email protected] for quotation 5 Å crystal structure of

5 Å crystal structure of the SIRT1 catalytic domain bound to nicotinamide adenine dinucleotide (NAD+) and an indole (EX527 analogue) reveals a novel mechanism of histone deacetylase inhibition

and 10 μM) significantly reduces the release of HSV-1 particles in OC3 cells

Solubility: DMSO : ≥ 100 mg/mL (323

Thapsigargin inhibits the carbachol-evoked [Ca2+]i-transients with (IC50=0

InChi: InChI=1S/C50H68N7O9PSi/c1-32(2)45(58)54-48-53-44-41(46(59)55-48)52-31-56(44)47-43(66-68(12

Metoclopramide hydrochloride hydrate Size:Contact [email protected] for quotation 5 Å crystal structure ofMetoclopramide hydrochloride hydrate is a dopamine D2 antagonist that is used as an antiemetic. IC50 Value: Target: D2 ReceptorMetoclopramide is a dopamine receptor antagonist which has been used for treatment of a variety of gastrointestinal symptoms over the last thirty years. In various countries, metoclopramide is the antiemetic drug of choice in pregnant women. Findings provide reassurance regarding the safety of metoclopramide for the fetus when